ABBV-599
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-599, covering 2021-05-03 to 2021-05-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis [Phase 2]